Evaluation finds Xpert MTB/RIF Ultra reduces airborne infection isolation duration in low tuberculosis settings, suggesting improvements in clinical efficiency.
Background: Rapid molecular diagnostics such as Xpert MTB/RIF Ultra (Xpert Ultra) are recommended to support airborne infection isolation (AII) discontinuation in patients with suspected pulmonary tuberculosis (pTB). However, real-world evidence evaluating its operational impact in low tuberculosis prevalence settings remains limited.
No takes yet. Share an insight, caveat, or question.
Chinnappan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: